港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

巨子生物

78.800

-2.000-2.48%

成交量：490.83萬

成交額：3.88億

市值：843.95億

市盈率：34.91

高：82.200

開：82.200

低：78.050

收：80.800

資料載入中...

總覽公司新聞公告

醫美行業洗牌：新勢力崛起，老玩家如何破局？

21世纪经济报道

【券商聚焦】德邦證券維持鉅子生物(02367)“買入”評級指其作為膠原蛋白龍頭有望隨成分熱度持續擴容

鉅子生物早盤漲超6% 股價創新高花旗給予“買入”評級

【港股異動 | 鉅子生物(02367.HK)漲超5% 】鉅子生物(02367.HK)漲超5%，高見63.3港元創上市以來新高。截至發稿，漲5.69%，報63.15港元，成交額1.43億港元。

港股異動 | 鉅子生物(02367)漲超5% 股價創上市新高旗下可復美推出重組IV型膠原蛋白新品

鉅子生物盤中異動早盤股價大漲5.02%報62.750港元

中國500強！陝西3家上榜→

PCHi 2025觀察：珠光顏料成彩妝“風向標”，多肽為個護品類“掌中寶”

招銀國際：內地藥品價格政策有望優化醫療AI加速商業化落地

花旗：予鉅子生物(02367)“買入”評級升目標價至68.2港元

《大行》花旗升鉅子生物(02367.HK)目標價至68.2元加快新產品上市建立專業品牌形象

阿斯达克财经

中國內地投資者週二港股通淨買入額創四年來最高

南向資金2月13日淨賣出鉅子生物66.52萬股連續5日減持

異動解讀 | 鉅子生物盤中大漲5.02% 重組膠原蛋白助力增長前景獲看好

鉅子生物盤中異動早盤大幅拉昇5.02%報61.750港元

中國化妝品未看到需求復甦？花旗：仍看好鉅子生物等

智通财经网

南向資金2月11日淨賣出鉅子生物124.92萬股連續3日減持

【券商聚焦】民生證券維持鉅子生物(02367)“推薦”評級看好後續醫美產品持續落地對業績的提振作用

【券商聚焦】招銀國際指中國醫藥開啓估值修復

招銀國際：看好中國醫藥行業估值修復推薦“買入”藥明康德(02359)等

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02367/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02367","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":78.8,"timestamp":1746605305017,"preClose":80.8,"halted":0,"volume":4908295,"delay":0,"floatShares":1071000000,"shares":1071000000,"eps":2.256983207569279,"marketStatus":"未開盤","change":-2,"latestTime":"05-07 16:08:25","open":82.2,"high":82.2,"low":78.05,"amount":387704197,"amplitude":0.051361,"askPrice":78.8,"askSize":68800,"bidPrice":78.75,"bidSize":10800,"shortable":3,"etf":0,"ttmEps":2.2136240932385554,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1746667800000},"marketStatusCode":0,"adr":0,"listingDate":1667491200000,"exchange":"SEHK","adjPreClose":80.8,"dividendRate":0.01231,"openAndCloseTimeList":[[1746581400000,1746590400000],[1746594000000,1746604800000]],"volumeRatio":0.97999,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02367\",,,,,undefined,":{"symbol":"02367","floatShares":1071000000,"roa":"21.92%","roe":"35.88%","lyrEps":2.256983,"volumeRatio":0.97999,"shares":1071000000,"dividePrice":0.97,"high":82.2,"amplitude":0.051361,"preClose":80.8,"low":78.05,"week52Low":35,"pbRate":"11.05","psRate":"14.18","week52High":83.35,"institutionHeld":0,"latestPrice":78.8,"committee":-0.728643,"eps":2.256983207569279,"divideRate":0.01231,"volume":4908295,"delay":0,"ttmEps":2.2136240932385554,"open":82.2,"prevYearClose":49.9,"prevWeekClose":80.5,"prevMonthClose":80,"prevQuarterClose":70.45,"fiveDayClose":78.95,"twentyDayClose":71.25,"sixtyDayClose":58},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02367\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514841645","title":"醫美行業洗牌：新勢力崛起，老玩家如何破局？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514841645","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514841645?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 13:30","pubTimestamp":1740634229,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者韩利明上海报道在医美消费疲软、求美者需求变化等因素的共同作用下，医美上市企业各有忧喜。日前，北交所“重组胶原蛋白第一股”锦波生物发布2024年年度业绩快报显示，报告期内实现营业收入14.47亿元，同比增长85.4%；归母净利润7.33亿元，同比增长144.65%；归母扣非净利润7.13亿元，同比增长149.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502273331473289.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273331473289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09996","09997","02367","BK1207","BK1574","BK1583","LU2488822045.USD","BK1222","BK1100"],"gpt_icon":0},{"id":"2514000490","title":"【券商聚焦】德邦證券維持鉅子生物(02367)“買入”評級  指其作為膠原蛋白龍頭 有望隨成分熱度持續擴容","url":"https://stock-news.laohu8.com/highlight/detail?id=2514000490","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514000490?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 16:02","pubTimestamp":1740556953,"startTime":"0","endTime":"0","summary":"金吾财讯 | 德邦证券发研指，胶原蛋白成分市场仍处于成长期，远未到成熟期，相比于玻尿酸、胜肽等成分仍有较大空间，且当前市场竞争者寡，未来随着珀莱雅、丸美等更多新国货进场可共同做大胶原市场空间，而巨子生物 作为胶原蛋白市场龙头，有望跟随成分热度持续扩容。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NWI3NDNkNGUxZmM1MTMzOTE0MzEwMTk=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953952","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","02367"],"gpt_icon":0},{"id":"2514912079","title":"鉅子生物早盤漲超6% 股價創新高花旗給予“買入”評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2514912079","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514912079?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 11:44","pubTimestamp":1740541440,"startTime":"0","endTime":"0","summary":"　　巨子生物早盘涨超6%，高见63.55港元，创上市以来新高。截至发稿，股价上涨6.36%，报63.55港元，成交额1.60亿港元。给予巨子生物“买入”评级，基于2025年预测市盈率约25倍，将目标价由61港元上调至68.2港元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-02-26/doc-inemurfp9031526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02367"],"gpt_icon":0},{"id":"2514757230","title":"【港股異動 | 鉅子生物(02367.HK)漲超5% 】鉅子生物(02367.HK)漲超5%，高見63.3港元創上市以來新高。截至發稿，漲5.69%，報63.15港元，成交額1.43億港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514757230","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514757230?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 11:08","pubTimestamp":1740539309,"startTime":"0","endTime":"0","summary":"巨子生物(02367.HK)涨超5%，高见63.3港元创上市以来新高。截至发稿，涨5.69%，报63.15港元，成交额1.43亿港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26110848392800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02367","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2514182075","title":"港股異動 | 鉅子生物(02367)漲超5% 股價創上市新高 旗下可復美推出重組IV型膠原蛋白新品","url":"https://stock-news.laohu8.com/highlight/detail?id=2514182075","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514182075?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 11:03","pubTimestamp":1740539000,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，巨子生物涨超5%，高见63.3港元创上市以来新高。截至发稿，涨5.69%，报63.15港元，成交额1.43亿港元。消息面上，近日，巨子生物旗下品牌可复美推出了首个针对修护皮肤热损伤的系列产品——可复美帧域密修系列。值得关注的是，可复美帧域密修系列的核心功效成分首次应用了巨子生物全新研发的Ⅳ型热塑胶原。给予巨子生物“买入”评级，基于2025年预测市盈率约25倍，将目标价由61港元上调至68.2港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254454.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2514650078","title":"鉅子生物盤中異動 早盤股價大漲5.02%報62.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514650078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514650078?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 10:02","pubTimestamp":1740535374,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘10时02分，巨子生物股票出现异动，股价快速拉升5.02%。截至发稿，该股报62.750港元/股，成交量178.732万股，换手率0.17%，振幅5.10%。资金方面，该股资金流入2107.36万港元，流出1275.36万港元。巨子生物股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，科济药业-B、来凯医药-B、创胜集团-B涨幅较大，振幅较大的相关个股有科济药业-B、来凯医药-B、创胜集团-B，振幅分别为23.55%、15.02%、14.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261002549630844d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502261002549630844d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"2514063215","title":"中國500強！陝西3家上榜→","url":"https://stock-news.laohu8.com/highlight/detail?id=2514063215","media":"西部网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514063215?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 17:20","pubTimestamp":1740475200,"startTime":"0","endTime":"0","summary":"2月25日胡润研究院发布《2024胡润中国500强》榜单列出我国500强非国有企业按照企业价值进行排名陕西3家企业上榜榜单显示，台积电价值上涨3.27万亿元，以6.98万亿元再次蝉联中国价值最高的民营企业；腾讯价值上涨5700亿元，以3.42万亿元稳居第二；字节跳动价值上涨2300亿元，以1.63万亿元上升一位至第三；华为重返前十，价值大幅上涨1100亿元，以6800亿元位列第十。地域分布图榜单显示，陕西共有3家企业上榜，分别是隆基绿能、巨子生物和蓝晓科技。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-02-25/doc-inemswwc1200523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1781817850.SGD","LU2153592121.USD","LU1997245094.SGD","LU1655091616.SGD","BK0187","LU0327786744.USD","BK1207","LU2153591404.USD","LU1969619763.USD","LU0312595415.SGD","LU1328615791.USD","LU2242644610.SGD","02367","LU1997245177.USD","LU0140636845.USD","LU0048580855.USD","BK0175","LU2328871848.SGD","LU0326950275.SGD","601012","SGXZ81163826.USD","BK0028","LU0181495838.USD","LU2148510915.USD","LU1820825898.SGD","LU1242518931.SGD","BK0224","LU1580142542.USD","LU2348773727.SGD","BK0196","LU0979878070.USD","BK0054","LU1064130708.USD","LU2348774022.SGD","BK0188","LU0228659784.USD","LU2488822045.USD","BK0201","LU0370786039.SGD","LU1064131003.USD","LU1242518857.USD","LU0572944931.SGD","LU1146622755.USD","SGXZ49509284.SGD"],"gpt_icon":0},{"id":"2514667058","title":"PCHi 2025觀察：珠光顏料成彩妝“風向標”，多肽為個護品類“掌中寶”","url":"https://stock-news.laohu8.com/highlight/detail?id=2514667058","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514667058?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 14:16","pubTimestamp":1740464218,"startTime":"0","endTime":"0","summary":"第15届中国国际化妆品个人及家庭护理用品原料展览会于2月19-21日在广州举办。根据展会信息，PCHi 2025汇聚全球20多个国家，800家化妆品原料、检测、设备相关企业参展，展览面积超过6万平方米。PCHi展会历来是业内人士的必争之地，而PCHi 2025更是为参展企业提供了一个展示自身实力、提升品牌形象的绝佳舞台。由于衰老是所有化妆品消费者所面临的共同“难题”，因此对延缓个体或生物体衰老过程，成为护肤行业经久不衰，热度最高的主题。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/OWQ4NGY3MGJmOTZjMTUwZjdhOTdjYjQwNjE1MDM0NDE4NQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OWQ4NGY3MGJmOTZjMTUwZjdhOTdjYjQwNjE1MDM0NDE4NQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953846","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02145","LU0320764599.SGD","01318","BK1141","LU2488822045.USD","LU0052750758.USD","LU2242644610.SGD","06821","02367","LU2045819591.USD","BK1207","BK1587","LU1046422090.SGD","LU0708995583.HKD","BK1576","06616","BK1129","BK1191","02359","LU2125910500.SGD","BK1583"],"gpt_icon":0},{"id":"2514129084","title":"招銀國際：內地藥品價格政策有望優化 醫療AI加速商業化落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2514129084","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514129084?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 09:50","pubTimestamp":1740448233,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，维持内地医药行业“优于大市评级”。MSCI中国医疗指数2025年初至今累计上涨11.5%，跑输MSCI中国指数1.2%。受益于国内药品价格政策优化、国内宏观环境改善以及海外降息预期，医药行业有望在2025年继续迎来估值修复。报告指，丙类医保目录年内即将落地，创新药将覆盖获得更好的支付环境；医疗设备招标加速复苏，将推动国产医疗设备企业盈利复苏。该行看好行业估值修复，推荐买入信达生物(01801)、百济神州(06160)、三生制药(01530)、联影医疗(688271.SH)、巨子生物(02367)、药明康德(02359)、科伦博泰生物-B(06990)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01801","LU1969619763.USD","BK1207","BK1593","BK1576","02367","150261","02359","BK1588","LU2242644610.SGD","LU2045819591.USD","LU0307460666.USD","LU0708995583.HKD","BK1589","BK1583","LU0320764599.SGD","BK1500","LU0588546209.SGD","LU0052750758.USD","06160","LU2328871848.SGD","LU1046422090.SGD","01530","LU2125910500.SGD","LU2488822045.USD","BK1161","BK1141"],"gpt_icon":0},{"id":"2512416076","title":"花旗：予鉅子生物(02367)“買入”評級 升目標價至68.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512416076","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512416076?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 17:12","pubTimestamp":1740042726,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，花旗发布研报称，给予巨子生物(02367)“买入”评级，基于2025年预测市盈率约25倍，将目标价由61港元上调至68.2港元。该行称巨子生物是消费者对产品科学性的重视日益增长以及对肌肤修护需求不断上升的主要受益者。据悉，巨子生物近日推出了一个新的产品系列“帧域密修”，该系列以其新的专利重组胶原蛋白成分，针对热损伤后的肌肤护理，尤其是光电治疗后的护理，令公司的修护产品线从基础和一般修护，拓展到更专业及精准护理领域，有助带来新收入来源、巩固其以科学为导向的产品定位，并建立了专业品牌形象。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1252224.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0},{"id":"2512497222","title":"《大行》花旗升鉅子生物(02367.HK)目標價至68.2元  加快新產品上市建立專業品牌形象","url":"https://stock-news.laohu8.com/highlight/detail?id=2512497222","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512497222?lang=zh_tw&edition=fundamental","pubTime":"2025-02-20 15:29","pubTimestamp":1740036540,"startTime":"0","endTime":"0","summary":"花旗发表研报指，巨子生物(02367.HK) 近日推出了一个新的产品系列“帧域密修”，该系列以其新的专利重组胶原蛋白成分，针对热损伤后的肌肤护理，尤其是光电治疗后的护理，令巨子生物的修护产品线从基础和一般修护，拓展到更专业及精准护理领域，有助带来新收入来源、巩固其以科学为导向的产品定位，并建立了专业品牌形象。花旗相信，巨子生物是消费者对产品科学性的重视日益增长以及对肌肤修护需求不断上升的主要受益者，给予“买入”评级，基于2025年预测市盈率约25倍，将目标价由61元上调至68.2元。(gc/a)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-20 12:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221209170559652_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221209170559652_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1418858/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02367"],"gpt_icon":0},{"id":"2512111961","title":"中國內地投資者週二港股通淨買入額創四年來最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111961","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512111961?lang=zh_tw&edition=fundamental","pubTime":"2025-02-19 07:37","pubTimestamp":1739921873,"startTime":"0","endTime":"0","summary":"中国内地投资者周二通过港股通净买入224亿港元的香港股票，继续推动DeepSeek引发的科技股涨势。彭博数据显示，这是自2021年初以来最大单日净买入，也是有纪录以来第四高。恒生科技指数当日大涨2.5%，有望连续第六周上涨。内地资金大量涌入香港股市，已推动A股市场相较港股的溢价幅度缩小至约34%，这使得一项A-H股溢价指数接近在过去总会触发反弹的底部，引发了香港上市中资股跑赢内地股票的幅度可能缩小的担忧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02333","01119","01907","01787","03692","03918","00177","HSTECH","06618","03606","02099","02268","03360","00855","00826","00288","00384","02121","01138","00981","02096","00005","01052","00107","09992","01193","01341","01921","BK1506","01513","00412","BK1133","00003","02359","00868","02018","02291","09858","00867","01658","00762","02186","09626","03968","02157","02367","03800","00175","06110","00267","02162","09926","01772","03988","02155","09923","00728","09868","01405","00317","00991","02057","06680","01310","SG9999002463.SGD","01112","03396","00142","06060","09995","01860","01347","01818","01618","01585","01963","00006","00777","01070","02380","06069","01766","06616","02208","01929","00788","09987","03328","01888","02015","01579","03650","03888","06818","00220","02016","01071","01686","BK1589","00512","01952","02607","HSCEI","00152","00257","01177","02618","03311","00189","09696","00371","00856","01093","06186","01199","00853","00270","01211","02465","01128","03690","09885","00939","02282","06160","02105","03369","00241","01855","01919","03933","00014","00467","02269","00316","00293","00772","02601","00548","09890","00144","00590","01691","02498","06699","06808","01357","00751","00008","00659","01810","00576","03969","00425","02382","00148","06821","01876","09969","06990","03618","02533","06198","09899","02600","09922","09880","00038","06127","09988","02158","01519","06855","00546","01066","06690","06936","02338","01530","00392","02400","01024","00327","00861","01735","09688","02883","02171","00013","00300","02402","00666","00303","01541","02172","06181","01675","00819","02005","02688","00836","01558","01789","02386","BK1536"],"gpt_icon":0},{"id":"2511683699","title":"南向資金2月13日淨賣出鉅子生物66.52萬股 連續5日減持","url":"https://stock-news.laohu8.com/highlight/detail?id=2511683699","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511683699?lang=zh_tw&edition=fundamental","pubTime":"2025-02-14 09:30","pubTimestamp":1739496623,"startTime":"0","endTime":"0","summary":"2月13日，南向资金减持巨子生物66.52万股连续5日减持。截止当日收盘，港股通共持有巨子生物15790.41万股，占流通股15.23%。港股通减持金额前五个股分别为腾讯控股、美团-W、快手-W、中芯国际、比亚迪股份。巨子生物近5个交易日上涨2.62%，港股通累计减持395.68万股；近20个交易日上涨20.72%，港股通累计减持1091.51万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214093300a245325f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214093300a245325f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","LU2488822045.USD","02367"],"gpt_icon":0},{"id":"1189382666","title":"異動解讀 | 鉅子生物盤中大漲5.02%  重組膠原蛋白助力增長前景獲看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1189382666","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189382666?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 10:05","pubTimestamp":1739412319,"startTime":"0","endTime":"0","summary":"巨子生物(02367)今日盘中大涨5.02%,报61.750港元,成交额330万港元。\n\n消息面上,花旗银行近期行业调研认为,目前尚未看到化妆品需求复苏的迹象,预计未来一年行业形势严峻。但看好巨子生物等本土企业有望继续从外国品牌手中夺取市场份额。\n\n花旗指出,巨子生物在应用于大规模生产重组胶原蛋白的合成生物技术方面处于领先地位,得益于政策支持和抗衰老需求,其重组胶原蛋白产品生命周期比预期更长。重组胶原蛋白等功能性成分是巨子生物产品的核心,通过与网红合作等方式加强了品牌科学可信度和营销力度,形成了一定壁垒。综合来看,花旗给予巨子生物61港元的目标价,认为其更快的增长前景获得充分体现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02367"],"gpt_icon":0},{"id":"2511551927","title":"鉅子生物盤中異動 早盤大幅拉昇5.02%報61.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511551927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511551927?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 09:30","pubTimestamp":1739410222,"startTime":"0","endTime":"0","summary":"2025年02月13日早盘09时30分，巨子生物股票出现波动，股价急速拉升5.02%。截至发稿，该股报61.750港元/股，成交量17.9万股，换手率0.02%，振幅3.23%。资金方面，该股资金流入332.156万港元，流出213.121万港元。巨子生物股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，巨子生物、再鼎医药、和铂医药-B涨幅较大，振幅较大的相关个股有巨子生物、和铂医药-B、来凯医药-B，振幅分别为3.23%、2.35%、1.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213093023a243e342&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213093023a243e342&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02367","BK1207"],"gpt_icon":0},{"id":"2511116555","title":"中國化妝品未看到需求復甦？花旗：仍看好鉅子生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2511116555","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511116555?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 08:59","pubTimestamp":1739408386,"startTime":"0","endTime":"0","summary":"在花旗近期进行行业调研后，预计未来一年形势严峻，目前尚未看到需求复苏的迹象。在化妆品领域，花旗看好巨子生物，因其在消费者对产品科学性认知不断提升的趋势中处于最有利地位，尤其是在人工智能时代；而对于珀莱雅，花旗认为在管理层变动后，其受到干扰的风险有限，因为不确定性已在很大程度上被计入价格。鉴于珀莱雅强大的现金流以及投资者在看待化妆品公司时相对长期的视角。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213091135a243ddba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213091135a243ddba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","LU2488822045.USD","BK1207"],"gpt_icon":0},{"id":"2510395697","title":"南向資金2月11日淨賣出鉅子生物124.92萬股 連續3日減持","url":"https://stock-news.laohu8.com/highlight/detail?id=2510395697","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510395697?lang=zh_tw&edition=fundamental","pubTime":"2025-02-12 09:30","pubTimestamp":1739323826,"startTime":"0","endTime":"0","summary":"2月11日，南向资金减持巨子生物124.92万股连续3日减持。截止当日收盘，港股通共持有巨子生物15894.37万股，占流通股15.33%。巨子生物近5个交易日下跌0.26%，港股通累计减持340.24万股；近20个交易日上涨24.38%，港股通累计减持1133.42万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212093328abcb957e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212093328abcb957e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02367","BK1207"],"gpt_icon":0},{"id":"2510888795","title":"【券商聚焦】民生證券維持鉅子生物(02367)“推薦”評級 看好後續醫美產品持續落地對業績的提振作用","url":"https://stock-news.laohu8.com/highlight/detail?id=2510888795","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510888795?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 15:49","pubTimestamp":1739173763,"startTime":"0","endTime":"0","summary":"考虑公司具备较强的研发能力和技术优势，看好后续医美产品持续落地对业绩的提振作用。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/YzMzOTE1NTA2MzA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/YzMzOTE1NTA2MzA=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952825","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","02367"],"gpt_icon":0},{"id":"2510889645","title":"【券商聚焦】招銀國際指中國醫藥開啓估值修復","url":"https://stock-news.laohu8.com/highlight/detail?id=2510889645","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510889645?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 14:58","pubTimestamp":1739170729,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2025年初至今累计上涨5.3%，跑赢MSCI中国指数0.9%。医疗设备招标加速复苏，将推动国产医疗设备企业盈利复苏。该行认为，中国将成为海外药企寻找创新药管线的必选之地，中国创新药将在国际舞台扮演愈加重要的角色。丙类医保目录计划年内落地，商业医疗保险助力打开创新药支付天花板。该行认为，医保预付金和即时结算制度将有效缓解产业链的资金压力，利好商业流通、医疗机构等。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952816","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995583.HKD","LU1046422090.SGD","01801","600056","02367","BK0028","BK0082","BK0250","LU1969619763.USD","BK0188","LU0052750758.USD","LU0196878994.USD","BK1141","LU0320764599.SGD","BK0185","BK1161","BK0175","BK0010","06990","BK1589","BK1576","LU2328871848.SGD","LU2488822045.USD","LU2045819591.USD","LU2125910500.SGD","02359","BK1207","01530","LU2242644610.SGD","BK1593","BK1583"],"gpt_icon":0},{"id":"2510207759","title":"招銀國際：看好中國醫藥行業估值修復 推薦“買入”藥明康德(02359)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2510207759","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510207759?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 09:46","pubTimestamp":1739151985,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研究报告称，看好中国医药行业估值修复。招银国际主要观点如下：MSCI中国医疗指数2025年初至今累计上涨5.3%，跑赢MSCI中国指数0.9%。该行认为，中国将成为海外药企寻找创新药管线的必选之地，中国创新药将在国际舞台扮演愈加重要的角色。国家医保局将采取多种激励措施，积极引导支持商业健康保险将丙类目录药品纳入保障范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0320764599.SGD","LU0456842615.SGD","BK1141","LU0196878994.USD","LU2125910500.SGD","01530","603259","BK1583","BK1576","LU1969619763.USD","LU1997245094.SGD","BK0082","BK0010","LU0052750758.USD","LU0708995583.HKD","LU2045819591.USD","LU2242644610.SGD","BK0028","LU1046422090.SGD","02359","LU1997245177.USD","02367","BK1589","BK0250","BK0185","LU2328871848.SGD","BK1593","BK0188","600056","06990","LU2488822045.USD","BK1161","BK0216","BK1207","01801","BK0175"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02367\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"02367","amount":0.5921,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-06-18","defaultRemindTime":1750123800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-29","payableDate":"2025-06-18","currency":"CNY","dateTimestamp":1750089600000,"payDate":"2025-08-29"},{"date":"2025-03-26","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盤後","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-19","symbol":"02367","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-06-17","symbol":"02367","amount":0.97,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2024-06-18","defaultRemindTime":1718587800000,"name":"巨子生物","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-06-18","currency":"HKD","dateTimestamp":1718553600000,"payDate":"2024-07-05"},{"date":"2024-03-25","symbol":"02367","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02367\",market:\"HK\",,,undefined,":[{"executeDate":"2024-06-17","recordDate":"2024-06-18","paymentDate":"2024-07-05","value":0.97,"currency":"HKD"},{"executeDate":"2025-06-17","recordDate":"2025-06-18","paymentDate":"2025-08-29","value":0.5921,"currency":"CNY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02367\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4737,"buy":0.5263,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1745337600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02367\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02367","date":"2025-05-06","current":38.909936,"percent":0.916256,"low":18.546195,"twenty":25.869594,"median":29.388678,"eighty":34.273121,"high":60.214956,"avg":30.532196,"sd":6.569271,"marketCap":85537600132},"quantilePoints":[{"date":"2022-11-04","current":28.694216,"twenty":26.512834,"median":26.542085,"eighty":27.833364,"marketCap":25968654960},{"date":"2022-11-11","current":35.577583,"twenty":27.402937,"median":34.819032,"eighty":37.211633,"marketCap":32485133920},{"date":"2022-11-18","current":30.409033,"twenty":29.071802,"median":32.325114,"eighty":36.373143,"marketCap":27670720360},{"date":"2022-11-25","current":29.089974,"twenty":29.309257,"median":30.328688,"eighty":34.970742,"marketCap":26260437600},{"date":"2022-12-02","current":29.440115,"twenty":28.58665,"median":29.786096,"eighty":33.378719,"marketCap":27035200000},{"date":"2022-12-09","current":33.170723,"twenty":28.69893,"median":30.328688,"eighty":33.541593,"marketCap":30744000000},{"date":"2022-12-16","current":33.617702,"twenty":28.859591,"median":31.890871,"eighty":33.525219,"marketCap":31085600000},{"date":"2022-12-23","current":32.235512,"twenty":29.23003,"median":32.061881,"eighty":33.375102,"marketCap":29816800000},{"date":"2022-12-30","current":35.028223,"twenty":29.440115,"median":32.235512,"eighty":33.644993,"marketCap":32793600000},{"date":"2023-01-06","current":34.259259,"twenty":29.598569,"median":32.356077,"eighty":33.906187,"marketCap":32403200000},{"date":"2023-01-13","current":37.514633,"twenty":29.683286,"median":32.593587,"eighty":35.138095,"marketCap":36160800000},{"date":"2023-01-20","current":39.320225,"twenty":29.767789,"median":33.170723,"eighty":36.075015,"marketCap":37576000000},{"date":"2023-01-27","current":41.405428,"twenty":29.847916,"median":33.242723,"eighty":36.22764,"marketCap":39576800000},{"date":"2023-02-03","current":46.017337,"twenty":30.125824,"median":33.502098,"eighty":37.981351,"marketCap":44212800000},{"date":"2023-02-10","current":48.646066,"twenty":30.280481,"median":33.687805,"eighty":39.317619,"marketCap":46457600000},{"date":"2023-02-17","current":47.305048,"twenty":30.475064,"median":33.964048,"eighty":41.148897,"marketCap":44749600000},{"date":"2023-02-24","current":46.898265,"twenty":30.969524,"median":34.88282,"eighty":44.591745,"marketCap":43822400000},{"date":"2023-03-03","current":48.206405,"twenty":31.89643,"median":35.69024,"eighty":46.759698,"marketCap":45335200000},{"date":"2023-03-17","current":60.214956,"twenty":31.932315,"median":36.041848,"eighty":47.552658,"marketCap":56754400000},{"date":"2023-03-24","current":51.699724,"twenty":32.016899,"median":36.568073,"eighty":48.347792,"marketCap":49288000000},{"date":"2023-03-31","current":40.925047,"twenty":32.156582,"median":37.514633,"eighty":48.347792,"marketCap":46848000000},{"date":"2023-04-06","current":40.652856,"twenty":32.21578,"median":38.432644,"eighty":48.279626,"marketCap":46506400000},{"date":"2023-04-14","current":37.246115,"twenty":32.289273,"median":38.307612,"eighty":48.226605,"marketCap":42651200000},{"date":"2023-04-21","current":33.385259,"twenty":32.343692,"median":38.098031,"eighty":47.893759,"marketCap":38210400000},{"date":"2023-04-28","current":30.285025,"twenty":32.289273,"median":37.591448,"eighty":47.642868,"marketCap":34404000000},{"date":"2023-05-05","current":26.161165,"twenty":31.945964,"median":37.33158,"eighty":47.490756,"marketCap":29768000000},{"date":"2023-05-12","current":30.574645,"twenty":30.692284,"median":36.23263,"eighty":47.274687,"marketCap":34550400000},{"date":"2023-05-19","current":31.711515,"twenty":30.746535,"median":35.923479,"eighty":47.115193,"marketCap":35331200000},{"date":"2023-05-25","current":31.182824,"twenty":30.822604,"median":35.69024,"eighty":46.935066,"marketCap":34599200000},{"date":"2023-06-02","current":32.039153,"twenty":30.742861,"median":35.028223,"eighty":46.759698,"marketCap":35428800000},{"date":"2023-06-09","current":32.262222,"twenty":30.684805,"median":34.15987,"eighty":46.167812,"marketCap":35624000000},{"date":"2023-06-16","current":32.772734,"twenty":30.742861,"median":33.693297,"eighty":45.892894,"marketCap":36014400000},{"date":"2023-06-23","current":31.032471,"twenty":30.757557,"median":33.682729,"eighty":45.395124,"marketCap":33916000000},{"date":"2023-06-30","current":31.360803,"twenty":30.757557,"median":33.502098,"eighty":44.617559,"marketCap":33964800000},{"date":"2023-07-07","current":31.376956,"twenty":30.759705,"median":33.358016,"eighty":44.488487,"marketCap":33916000000},{"date":"2023-07-14","current":31.254408,"twenty":30.81937,"median":33.206723,"eighty":42.385946,"marketCap":34257600000},{"date":"2023-07-21","current":29.61115,"twenty":30.759705,"median":32.931722,"eighty":41.535665,"marketCap":32305600000},{"date":"2023-07-28","current":31.165322,"twenty":30.717545,"median":32.723027,"eighty":41.405428,"marketCap":33964800000},{"date":"2023-08-04","current":32.76763,"twenty":30.739187,"median":32.639512,"eighty":41.393979,"marketCap":35770400000},{"date":"2023-08-11","current":32.773868,"twenty":30.757557,"median":32.603384,"eighty":41.176747,"marketCap":35575200000},{"date":"2023-08-18","current":30.610294,"twenty":30.757557,"median":32.513854,"eighty":41.037499,"marketCap":32988800000},{"date":"2023-08-25","current":31.726668,"twenty":30.759705,"median":32.346784,"eighty":40.925047,"marketCap":34208800000},{"date":"2023-09-01","current":27.573424,"twenty":30.671209,"median":32.32831,"eighty":40.652856,"marketCap":36697600000},{"date":"2023-09-08","current":26.75169,"twenty":30.572064,"median":32.277824,"eighty":40.648282,"marketCap":35184800000},{"date":"2023-09-15","current":25.993592,"twenty":30.285025,"median":32.235512,"eighty":40.62978,"marketCap":34452800000},{"date":"2023-09-22","current":25.737943,"twenty":29.809068,"median":32.045764,"eighty":40.128892,"marketCap":33964800000},{"date":"2023-09-29","current":25.066298,"twenty":29.656075,"median":31.997803,"eighty":39.81665,"marketCap":33135200000},{"date":"2023-10-06","current":25.484582,"twenty":29.406098,"median":31.918666,"eighty":39.533705,"marketCap":33672000000},{"date":"2023-10-13","current":24.08012,"twenty":28.952772,"median":31.841433,"eighty":39.348774,"marketCap":31768800000},{"date":"2023-10-20","current":22.598372,"twenty":28.090884,"median":31.767659,"eighty":39.309801,"marketCap":29768000000},{"date":"2023-10-27","current":22.348635,"twenty":27.619397,"median":31.711663,"eighty":39.282609,"marketCap":29426400000},{"date":"2023-11-03","current":25.394448,"twenty":27.541831,"median":31.642548,"eighty":39.168886,"marketCap":33525600000},{"date":"2023-11-10","current":25.843419,"twenty":27.016595,"median":31.492944,"eighty":38.901953,"marketCap":34111200000},{"date":"2023-11-17","current":25.355932,"twenty":26.744612,"median":31.467436,"eighty":38.544946,"marketCap":33769600000},{"date":"2023-11-24","current":25.803053,"twenty":26.578324,"median":31.402883,"eighty":38.289787,"marketCap":34648000000},{"date":"2023-12-01","current":25.805078,"twenty":26.361375,"median":31.373452,"eighty":38.186355,"marketCap":34794400000},{"date":"2023-12-08","current":23.911147,"twenty":26.187226,"median":31.314709,"eighty":38.124793,"marketCap":32110400000},{"date":"2023-12-15","current":23.015122,"twenty":25.978956,"median":31.279712,"eighty":37.928033,"marketCap":31085600000},{"date":"2023-12-22","current":23.970526,"twenty":25.934891,"median":31.256547,"eighty":37.726838,"marketCap":32354400000},{"date":"2023-12-29","current":25.605578,"twenty":25.922833,"median":31.253927,"eighty":37.637537,"marketCap":34745600000},{"date":"2024-01-05","current":24.881987,"twenty":25.805078,"median":31.237017,"eighty":37.514633,"marketCap":33525600000},{"date":"2024-01-12","current":25.701327,"twenty":25.757517,"median":31.165322,"eighty":37.417045,"marketCap":34648000000},{"date":"2024-01-19","current":24.032983,"twenty":25.700075,"median":31.138965,"eighty":37.246115,"marketCap":32354400000},{"date":"2024-01-26","current":24.563567,"twenty":25.531167,"median":31.049171,"eighty":36.903516,"marketCap":32940000000},{"date":"2024-02-02","current":22.773078,"twenty":25.419215,"median":30.993085,"eighty":36.23263,"marketCap":30500000000},{"date":"2024-02-09","current":24.329361,"twenty":25.355932,"median":30.81937,"eighty":36.207681,"marketCap":32744800000},{"date":"2024-02-16","current":25.846624,"twenty":25.369207,"median":30.758631,"eighty":36.108181,"marketCap":34794400000},{"date":"2024-02-23","current":26.457355,"twenty":25.369207,"median":30.717545,"eighty":35.899805,"marketCap":35428800000},{"date":"2024-03-01","current":26.003824,"twenty":25.387892,"median":30.635655,"eighty":35.803782,"marketCap":34843200000},{"date":"2024-03-08","current":26.210688,"twenty":25.395134,"median":30.572064,"eighty":35.667709,"marketCap":35136000000},{"date":"2024-03-15","current":30.241869,"twenty":25.409765,"median":30.44783,"eighty":35.490153,"marketCap":40504000000},{"date":"2024-03-22","current":31.217759,"twenty":25.435494,"median":30.569793,"eighty":35.18968,"marketCap":41772800000},{"date":"2024-03-28","current":26.416103,"twenty":25.461641,"median":30.551779,"eighty":34.970062,"marketCap":41528800000},{"date":"2024-04-05","current":26.713065,"twenty":25.484582,"median":30.44783,"eighty":34.88282,"marketCap":41968000000},{"date":"2024-04-12","current":27.194611,"twenty":25.506915,"median":30.285025,"eighty":34.259259,"marketCap":42748800000},{"date":"2024-04-19","current":29.268508,"twenty":25.516475,"median":30.168532,"eighty":34.060481,"marketCap":45969600000},{"date":"2024-04-26","current":29.89571,"twenty":25.531167,"median":29.89571,"eighty":33.867614,"marketCap":46896800000},{"date":"2024-05-03","current":31.286129,"twenty":25.569811,"median":29.89571,"eighty":33.72816,"marketCap":49044000000},{"date":"2024-05-10","current":35.317002,"twenty":25.600357,"median":30.150227,"eighty":34.911901,"marketCap":51288800000},{"date":"2024-05-17","current":33.551674,"twenty":25.608792,"median":30.245106,"eighty":35.034138,"marketCap":48653600000},{"date":"2024-05-24","current":33.729665,"twenty":25.66112,"median":30.409033,"eighty":35.021714,"marketCap":48800000000},{"date":"2024-05-31","current":34.458991,"twenty":25.697876,"median":30.512617,"eighty":34.936642,"marketCap":49905929000},{"date":"2024-06-07","current":35.513458,"twenty":25.700826,"median":30.572064,"eighty":35.034138,"marketCap":51369298000},{"date":"2024-06-14","current":33.485895,"twenty":25.715973,"median":30.610294,"eighty":35.023883,"marketCap":48392099000},{"date":"2024-06-21","current":32.121521,"twenty":25.745773,"median":30.694377,"eighty":34.964455,"marketCap":46323198000},{"date":"2024-06-28","current":32.099848,"twenty":25.775731,"median":30.739187,"eighty":34.884174,"marketCap":46272737000},{"date":"2024-07-05","current":29.936022,"twenty":25.803458,"median":30.671209,"eighty":34.879736,"marketCap":43144155000},{"date":"2024-07-12","current":29.087996,"twenty":25.812746,"median":30.592469,"eighty":34.858532,"marketCap":41983552000},{"date":"2024-07-19","current":27.898783,"twenty":25.84406,"median":30.569793,"eighty":34.80307,"marketCap":40267878000},{"date":"2024-07-26","current":27.412372,"twenty":25.847354,"median":30.44783,"eighty":34.722361,"marketCap":39712807000},{"date":"2024-08-02","current":26.870727,"twenty":25.853895,"median":30.347362,"eighty":34.692602,"marketCap":38905431000},{"date":"2024-08-09","current":29.53175,"twenty":25.868681,"median":30.263126,"eighty":34.580226,"marketCap":43043233000},{"date":"2024-08-16","current":27.651468,"twenty":25.880225,"median":30.20526,"eighty":34.54918,"marketCap":40318339000},{"date":"2024-08-23","current":20.295155,"twenty":25.847354,"median":30.132576,"eighty":34.503268,"marketCap":39157736000},{"date":"2024-08-30","current":21.43279,"twenty":25.766624,"median":29.936022,"eighty":34.476088,"marketCap":41630325000},{"date":"2024-09-06","current":20.565575,"twenty":25.695677,"median":29.843348,"eighty":34.445054,"marketCap":39965112000},{"date":"2024-09-13","current":18.849184,"twenty":25.540828,"median":29.786096,"eighty":34.363297,"marketCap":36533764000},{"date":"2024-09-20","current":20.082561,"twenty":25.484582,"median":29.694562,"eighty":34.259259,"marketCap":39157736000},{"date":"2024-09-27","current":24.850231,"twenty":25.394448,"median":29.657792,"eighty":34.060481,"marketCap":48745326000},{"date":"2024-10-04","current":29.382648,"twenty":25.395362,"median":29.624666,"eighty":34.023673,"marketCap":57374157000},{"date":"2024-10-10","current":27.207172,"twenty":25.409765,"median":29.557165,"eighty":33.926357,"marketCap":52782206000},{"date":"2024-10-18","current":27.08831,"twenty":25.435494,"median":29.436062,"eighty":33.784845,"marketCap":52277596000},{"date":"2024-10-25","current":27.691447,"twenty":25.469288,"median":29.344363,"eighty":33.707844,"marketCap":53438199000},{"date":"2024-11-01","current":28.012496,"twenty":25.497982,"median":29.274876,"eighty":33.690002,"marketCap":54094192000},{"date":"2024-11-08","current":29.463901,"twenty":25.512651,"median":29.272452,"eighty":33.684759,"marketCap":56465859000},{"date":"2024-11-15","current":26.265769,"twenty":25.52529,"median":29.194481,"eighty":33.660087,"marketCap":49956390000},{"date":"2024-11-22","current":26.278217,"twenty":25.56015,"median":29.088985,"eighty":33.628618,"marketCap":49956390000},{"date":"2024-11-29","current":26.561468,"twenty":25.595136,"median":29.046664,"eighty":33.578085,"marketCap":50461000000},{"date":"2024-12-06","current":27.316407,"twenty":25.595136,"median":28.89327,"eighty":33.512207,"marketCap":51772986000},{"date":"2024-12-13","current":27.527865,"twenty":25.608792,"median":28.855293,"eighty":33.470601,"marketCap":52126213000},{"date":"2024-12-20","current":27.519045,"twenty":25.66112,"median":28.7635,"eighty":33.433798,"marketCap":51823447000},{"date":"2024-12-27","current":26.95045,"twenty":25.695677,"median":28.729978,"eighty":33.410147,"marketCap":50713305000},{"date":"2025-01-03","current":25.718533,"twenty":25.700075,"median":28.694216,"eighty":33.386493,"marketCap":48442560000},{"date":"2025-01-10","current":26.596222,"twenty":25.605578,"median":28.598093,"eighty":33.385259,"marketCap":49905929000},{"date":"2025-01-17","current":28.4557,"twenty":25.610934,"median":28.581538,"eighty":33.383573,"marketCap":53438199000},{"date":"2025-01-24","current":29.058848,"twenty":25.694577,"median":28.62658,"eighty":33.365541,"marketCap":54912816000},{"date":"2025-01-28","current":30.995109,"twenty":25.696776,"median":28.668851,"eighty":33.362531,"marketCap":58878741600},{"date":"2025-02-07","current":31.279146,"twenty":25.700576,"median":28.706002,"eighty":33.347316,"marketCap":59082122400},{"date":"2025-02-14","current":32.46032,"twenty":25.708209,"median":28.7635,"eighty":33.295849,"marketCap":61166775600},{"date":"2025-02-21","current":32.605291,"twenty":25.726297,"median":28.850334,"eighty":33.213923,"marketCap":61776918000},{"date":"2025-02-28","current":33.709306,"twenty":25.745773,"median":28.875802,"eighty":33.347316,"marketCap":63658190400},{"date":"2025-03-07","current":37.167941,"twenty":25.761386,"median":29.014465,"eighty":33.385999,"marketCap":70471447200},{"date":"2025-03-14","current":37.985438,"twenty":25.781535,"median":29.070262,"eighty":33.525362,"marketCap":72047648400},{"date":"2025-03-21","current":37.329923,"twenty":25.803863,"median":29.089974,"eighty":33.667635,"marketCap":70776518400},{"date":"2025-03-28","current":31.329348,"twenty":25.820414,"median":29.153791,"eighty":33.6911,"marketCap":69149472000},{"date":"2025-04-03","current":32.960917,"twenty":25.84406,"median":29.176551,"eighty":33.68679,"marketCap":72606945600},{"date":"2025-04-11","current":32.158951,"twenty":25.847354,"median":29.194481,"eighty":33.675182,"marketCap":70369756800},{"date":"2025-04-17","current":33.426462,"twenty":25.850275,"median":29.270028,"eighty":33.693297,"marketCap":73318778400},{"date":"2025-04-25","current":35.713683,"twenty":25.864757,"median":29.297766,"eighty":33.896985,"marketCap":78403298400},{"date":"2025-05-02","current":37.455761,"twenty":25.86929,"median":29.382648,"eighty":34.212713,"marketCap":82402510032},{"date":"2025-05-06","current":38.909936,"twenty":25.869594,"median":29.388678,"eighty":34.273121,"marketCap":85537600132}],"updateTime":1746642237496}}}